| (SEK) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 34.32M | — |
| Operating expense | — | — |
| Net income | 1.31M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GENO.ST returned -16.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -5.9% |
| 1 year | -16.7% |
| 5 years | -67.7% |
| 10 years | +930.9% |
| All-time high | kr 76.70 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in GENO.ST would be worth today ›No. Genovis AB (publ.) has not paid a dividend in the past 12 months.
Genovis AB (publ.) is part of the Healthcare sector.
Genovis AB (publ.) has a market cap of 1.35B SEK, based on the latest quote.
